Canadian Cancer Trials Group Bulletins

Trial Management Group


Trial Activation

CEC.1/EORTC 26053-22054/RTOG 0834 -- Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial -- was centrally activated 22 July 2009.

http://www.ctg.queensu.ca/trials/brain/cec1/cec1.html